Cargando…
Rupatadine oral solution improves rhino-conjunctive symptoms control in children with 6-11 years weighing ≥25 kg with persistent allergic rhinitis
Autores principales: | Izquierdo, Iñaki, Potter, Paul, Maspero, Jorge, Vermeulen, Jan, Barkai, Laszlo, Nemeth, Ildiko, Baillieau, Rene, Garde M, Jesus M, Giralt, Josep, Domenech, Alejandro, Nieto, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716553/ http://dx.doi.org/10.1186/2045-7022-3-S2-P33 |
Ejemplares similares
-
O10 - Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2-11 years old)
por: Potter, Paul, et al.
Publicado: (2014) -
Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study
por: Santamaría, Eva, et al.
Publicado: (2018) -
Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
por: Marmouz, Farid, et al.
Publicado: (2011) -
Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study
por: Santamaria, Eva, et al.
Publicado: (2021) -
Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
por: Mullol, Joaquim, et al.
Publicado: (2019)